OmniAb (OABI) Current Deferred Revenue (2021 - 2026)
OmniAb (OABI) reported Current Deferred Revenue of $2.9 million for Q1 2026, up 70.59% year-over-year from $1.7 million in Q1 2025, and down 8.26% quarter-over-quarter from $3.2 million in Q4 2025.
OmniAb (OABI) Current Deferred Revenue (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Current Deferred Revenue data on file, last reported at $2.9 million in Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $2.9 million, up 70.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (up 70.59% YoY), and the FY2025 annual result was $3.2 million, up 26.44% from the prior year.
- Current Deferred Revenue eased to $2.9 million in Q1 2026 per OABI's latest filing, from $3.2 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $8.2 million in Q4 2022 and troughed at $1.0 million in Q2 2025.
- A 5-year average of $4.3 million and a median of $3.0 million in 2024 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue sank 69.26% in 2025, then soared 70.59% in 2026.
- A 5-year view of Current Deferred Revenue shows it stood at $8.2 million in 2022, then fell by 16.56% to $6.8 million in 2023, then sank by 63.49% to $2.5 million in 2024, then climbed by 26.44% to $3.2 million in 2025, then fell by 8.26% to $2.9 million in 2026.
- Business Quant data shows OABI's Current Deferred Revenue at $2.9 million in Q1 2026, $3.2 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | 3.16 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.91 Mn |
| Mar 31, 2024 | 5.53 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Sep 30, 2023 | 7.38 Mn |
| Jun 30, 2023 | 7.27 Mn |
| Mar 31, 2023 | 6.89 Mn |
| Dec 31, 2022 | 8.21 Mn |
| Dec 31, 2021 | 10.79 Mn |